Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Cronos Group Inc. operates as a diversified and vertically integrated cannabis company. The Company offers production and distribution platforms of medical marijuana, as well as cultivates cannabis oil. Cronos Group serves customers in Canada.
  • Current market environment: positive. Prices of production are 5.8% higher compared to the last 12 months (LTM)
  • Prices of production are at 23.2% percentile over the past 5 years, adjusted for inflation
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 30.5% (LTM), projected 30.3%
  • Share price is 59.3% higher than minimum and 21.1% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-1.7x vs
    )
  • The company is overvalued by EV / projected EBITDA multiple compared to target level (
    vs
    )

Key Financials (Download financials)

Ticker: CRON
Share price, USD:  (+1.2%)2.58
year average price 2.38  


year start price 1.75 2025-04-13

min close price 1.72 2025-04-14

max close price 3.27 2025-12-12

current price 2.58 2026-04-12
Common stocks: 371 656 593

Dividend Yield:  0.0%
FCF Yield LTM / expected: 30.5% / 30.3%
EV / LTM EBITDA: -1.7x
Production prices change from LTM: 5.8%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 959
Net Debt ($m): -860
EV (Enterprise Value): 99
EBITDA LTM ($m): -59
EV / LTM EBITDA: -1.7x
Price to Book: 0.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2026-02-02globenewswire.com

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy

2025-12-31zacks.com

Riding the Marijuana Reclassification Wave: 3 Stocks to Watch in 2026

2025-12-30seekingalpha.com

Cronos: A Standout Balance Sheet Among Its Peers

2025-12-11zacks.com

Are Medical Stocks Lagging Cronos Group (CRON) This Year?

2025-12-09247wallst.com

Cronos Just Bought Europe's Top Cannabis Producer — Is This the Catalyst Investors Have Waited 5 Years For?

2025-11-13cnbc.com

Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling

2025-08-27barrons.com

Bitcoin, Ethereum, XRP, Cronos Gain. 2 Ways Trump Is Boosting Cryptos.

2025-08-11seekingalpha.com

Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling

2025-08-07seekingalpha.com

Cronos Group Inc. (CRON) Q2 2025 Earnings Call Transcript

2025-08-07globenewswire.com

Cronos Group Reports 2025 Second Quarter Results
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company